Showing results (621-630 of 645) with videos related to

Sort By:
Pageof 65
Transplantation|February 2, 2023
Natural Antibodies Are Associated With Rejection and Long-term Renal Allograft Loss in a Multicenter International CohortSarah B See, Xue Yang, Carole Burger, et al.
Tree Physiology|May 26, 2017
Genes and gene clusters related to genotype and drought-induced variation in saccharification potential, lignin content and wood anatomical traits in Populus nigraHenning Wildhagen, Shanty Paul, Mike Allwright, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2017
Cell-Free DNA and Active Rejection in Kidney AllograftsRoy D Bloom, Jonathan S Bromberg, Emilio D Poggio, et al.
Gastroenterology|October 15, 2014
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infectionGregory J Dore, Eric Lawitz, Christophe Hézode, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2017
#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of PathologyDavid Cohen, Timothy Craig Allen, Serdar Balci, et al.
Laryngoscope Investigative Otolaryngology|February 16, 2024
Proposal for standardized ultrasound analysis of the salivary glands: Part 1 submandibular glandHenry T Hoffman, Michael Koch, Robert Lee Witt, et al.
Springerplus|September 3, 2016
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3Graham R Foster, Kazuaki Chayama, Wan-Long Chuang, et al.
Journal of the American College of Cardiology|August 17, 2023
Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary InterventionsGuiomar Mendieta, Shamir Mehta, Usman Baber, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Child and adolescent psychiatry: challenges, solutions, opportunities, and future directionsSamuele Cortese, Celso Arango, Claudia Aymerich, et al.
Neuroscience and Biobehavioral Reviews|March 31, 2023
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indicationsSamuele Cortese, Katherine McGinn, Mikkel Højlund, et al.
Pageof 65